Long-term results after liver transplantation

Transplant International

Volumn 21, Issue 3, 2008, Pages 234-246

  Pfitzmann, Robert ^a   Nüssler, Natascha C ^a   Hippler Benscheidt, Michael ^a   Neuhaus, Ruth ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Complications; Liver transplantation; Long term results; Survival

Indexed keywords

ALPHA INTERFERON; AMPHOTERICIN; ANTIVIRUS AGENT; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; FAMCICLOVIR; HYPERIMMUNE GLOBULIN; INSULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; LAMIVUDINE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; POLYMYXIN; RIBAVIRIN; STEROID; TACROLIMUS; TOBRAMYCIN;

ACUTE GRAFT REJECTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHOLESTATIC HEPATITIS; CHRONIC GRAFT REJECTION; CLINICAL FEATURE; DOSE RESPONSE; DRUG BLOOD LEVEL; FOLLOW UP; HEPATIC ARTERY; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; LONG TERM CARE; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SURVIVAL; THROMBOSIS; TREATMENT INDICATION; VASCULAR DISEASE;

ADULT; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS; TIME FACTORS;

EID: 38849095204     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00596.x     Document Type: Article

References (66)

1. Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation 2004 77 : S44.
2. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006 367 : 225.
3. Varotti G, Grazi GL, Vetrone G, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-center experience. Clin Transplant 2005 19 : 492.
4. The US Multicenter FK506 Liver Study Group: a comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994 331 : 1110.
5. European FK506 Multicentre Liver Study Group. Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994 344 : 423.
6. Neuhaus P, Blumhardt G, Bechstein WO, et al. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience. Transplantation 1995 59 : 31.
7. Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl 2003 9 : 1231.
8. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades. Ann Surg 2005 241 : 905.
9. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000 232 : 490.
10. Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 1999 19 : 311.
11. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 : 693.
12. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 2002 8 : 736.
13. Mueller AR, Platz KP, Kremer B. Early postoperative complications following liver transplantation. Best Pract Res Clin Gastroenterol. 2004 18 : 881.
14. Abbasoglu O, Levy MF, Brkic BB, et al. Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation 1995 64 : 1801.
15. Jain A, Reyes J, Kashyap R, et al. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1,000 patients Ann Surg 1999 230 : 441.
16. Salizzoni M, Cerutti E, Romagnoli R, et al. The first one thousand liver transplants in Turin: a single-center experience in Italy. Transpl Int 2005 18 : 1328.
17. Amador A, Charco R, Marti R, et al. One thousand liver transplants: the hospital clinic experience. Transplant Proc 2005 37 : 3916.
18. Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant 2003 17 : 401.
19. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transplant 2005 5 : 125.
20. Zwaveling JH, Maring JK, Klompmaker IJ, et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant patients. Crit Care Med 2002 30 : 1204.
21. Emre S, Sebastian A, Chodoff L, et al. Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med 1999 66 : 310.
22. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002 74 : 123.
23. Echaniz A, Pita S, Otero A, Suarez F, Gomez M, Guerrero A. Incidence, risk factors and influence on survival of infectious complications after liver transplantation. Entferm Infec Micribiol Clin 2003 21 : 224.
24. Neuberger J. Incidence, timing, and risk factors for acute and cR. Review. Liver Transpl Surg 1999 5 : S30.
25. Cohen AJ, Stegall MD, Rosen CB, et al. Chronic renal dysfunction late after liver transplantation. Liver Transplant 2002 8 : 916.
26. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transplant 2003 9 : 741.
27. Abbasoglu O, Levy MF, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation - incidence, presentation, treatment, and long term outcome. Transplantation 1997 63 : 250.
28. Jain A, Costa G, Marsh W, et al. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients. Transpl Int 2006 19 : 27.
29. Cavallari A, Vivarelli M, Belusci R, Jovine E, Mazziotti A, Rossi C. Treatment of vascular complications following liver transplantation: multidisciplinary approach. Hepatogastroenterology 2001 48 : 179.
30. Gunsar F, Rolando N, Pastacaldi S, et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl 2003 9 : 605.
31. Settmacher U, Stange B, Haase R, et al. Arterial complications after liver transplantation. Transpl Int 2001 13 : 372.
32. Settmacher U, Nussler NC, Glanemann M, et al. Venous complications after orthotopic liver transplantation. Clin Transplant 2000 14 : 235.
33. Gopal DV, Pfau PR, Lucey MR. Endoscopic management of biliary complications after orthotopic liver transplantation. Curr Treat Gastroenterol 2003 6 : 509.
34. Moser MAJ, Wall WJ. Management of biliary problems after liver transplantation. Liver Transpl 2001 7 (Suppl. 1 S46.
35. Nemec P, Ondrasek J, Studenik P, Hokl J, Cerny J. Biliary complications in liver transplantation. Ann Transplant 2001 6 : 24.
36. Asfar S, Metrakos P, Fryer J, et al. An analysis of late deaths after liver transplantation. Transplantation 1996 61 : 1377.
37. Pruhti J, Medkiff KA, Esrason KT, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transplant 2001 7 : 811.
38. Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving = or >5 years after liver transplant. Transplantation 2000 69 : 781.
39. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nussler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007 13 : 197.
40. Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: indication for transplantation. J Hepatobiliary Pancreat Surg 2003 10 : 282.
41. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002 73 : 901.
42. Duvoux C. De novo tumours after liver transplantation in adults. What is the actual risk? J Hepatol 2001 34 : 161.
43. Fung JF, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl 2001 7 : S109.
44. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001 34 : 84.
45. Sanchez EQ, Marubashi S, Jung G, et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002 8 : 285.
46. Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001 7 : 971.
47. Munoz SJ, Rothstein KD, Reich D, Manzarbeitia C. Long-term care of the liver transplant recipient. Clin Liver Dis 2000 4 : 691.
48. Manns MP, Neuhaus P, Atkinson GF, et al. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-center study. Transpl Infect Dis 2001 3 : 16.
49. Dumortier J, Chevallier P, Scoazec JY, Berger F, Boillot O. Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results. Am J Transplant 2003 3 : 999.
50. Bienzle U, Günther M, Neuhaus R, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. J Hepatol 2004 38 : 811.
51. Samuel D, Bizollon T, Feray C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003 124 : 642.
52. Blumhardt G, Lemmens P, Topalidis T, et al. Increased flow rate of preservation solution in the hepatic artery during organ preservation can improve postiscemic liver function. Transplant Proc 1993 25 : 2540.
53. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz K-P, Keck H. Technique and results of biliary reconstruction using side-to-side choledocho-choledochostomy in 300 orthotopic liver transplants. Ann Surg 1994 219 : 426.
54. Steinmüller T, Stockmann M, Bechstein WO, Settmacher U, Jonas S, Neuhaus P. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes 2000 108 : 401.
55. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002 8 : 708.
56. Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 2002 74 : 1007.
57. Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001 72 : 1066.
58. Blanco JJ, Herrero JI, Quiroga J, et al. Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl 2001 7 : 226.
59. Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transplant 2000 6 : 521.
60. Reich D, Rothstein K, Manzarbeitia C, Munoz SJ. Common medical diseases after liver transplantation. Semin Gastrointest Dis 1998 9 : 110.
61. Keeffe BG, Valentine H, Keeffe EB. Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001 7 : 755.
62. Ghaus N, Bohlega S, Rezeig M. Neurological complications in liver transplantation. J Neurol 2001 248 : 1042.
63. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients - incidence, timing, and long-term follow-up. Clin Transplant 2000 14 : 1.
64. Hay JE. Osteoporosis in liver diseases and after liver transplantation. J Hepatol 2003 38 : 856.
65. Barkmann A, Nashan B, Schmidt HHJ, et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolatemofetil. Transplantation 2000 69 : 1886.
66. Pfitzmann R, Klupp J, Langrehr JM, et al. Mycophenolatmofetil for immunosuppression after liver transplantation: a follow-up study of 191 patients. Transplantation 2003 76 : 130.